1 Min Read
Feb 20 (Reuters) - Halozyme Therapeutics Inc:
* HALOZYME REPORTS FOURTH QUARTER AND FULL-YEAR 2017 RESULTS
* REITERATED 2018 FINANCIAL GUIDANCE FOR NET REVENUE OF $115 MILLION TO $125 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.